Your browser doesn't support javascript.
loading
Cilastatin Preconditioning Attenuates Renal Ischemia-Reperfusion Injury via Hypoxia Inducible Factor-1α Activation.
Hong, Yu Ah; Jung, So Young; Yang, Keum Jin; Im, Dai Sig; Jeong, Kyung Hwan; Park, Cheol Whee; Hwang, Hyeon Seok.
  • Hong YA; Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul 06591, Korea.
  • Jung SY; Clinical Research Institute, Daejeon St. Mary's Hospital, Daejeon 34943, Korea.
  • Yang KJ; Clinical Research Institute, Daejeon St. Mary's Hospital, Daejeon 34943, Korea.
  • Im DS; Department of Chemistry, College of Natural Sciences, Soonchunhyang University, Asan 31538, Korea.
  • Jeong KH; SH Company, 507, SCH BIT Business Incubator B/D, 22 Soonchunhyang-ro, Shinchang, Asan, Chungnam 31538, Korea.
  • Park CW; Division of Nephrology, Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul 02447, Korea.
  • Hwang HS; Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Int J Mol Sci ; 21(10)2020 May 19.
Article en En | MEDLINE | ID: mdl-32438631
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cilastatina / Daño por Reperfusión / Precondicionamiento Isquémico / Riñón Límite: Animals / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cilastatina / Daño por Reperfusión / Precondicionamiento Isquémico / Riñón Límite: Animals / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article